Interferon-β1b Increases Th2 Response in Neuromyelitis Optica

A Japanese randomized controlled study showed that Interferon â (IFN-â1b) therapy is clinically effective in decreasing the frequency of attacks in multiple sclerosis (MS), even in optico-spinal MS (OSMS). However, recent studies have shown that IFN-â (IFN-â1a/IFN-â1b) treatment was not effective in...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakajima, Hideto, Hosokawa, Takafumi, Doi, Yoshimitu, Ikemoto, Toshiyuki, Ishida, Shimon, Kimura, Fumiharu, Hanafusa, Toshiaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Molecular Diversity Preservation International (MDPI) 2012
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3497267/
https://www.ncbi.nlm.nih.gov/pubmed/23202893
http://dx.doi.org/10.3390/ijms131012213

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3497267/
https://www.ncbi.nlm.nih.gov/pubmed/23202893
http://dx.doi.org/10.3390/ijms131012213

Ejemplares similares